Regenerative Therapies Library
Every article, presentation, spotlight, and news item we've tagged to Regenerative Therapies.
Showing 169–192 of 297
A Popular Senolytic Treatment Causes Brain Damage in Mice
Dasatinib and quercetin (D+Q), a widely used senolytic combination, impairs oligodendrocyte function and reduces myelination in the brain through endoplasmic reticulum stress, causing morphological changes similar to those seen in multiple sclerosis. This finding indicates that senolytic interventions carry neurological risks that warrant careful evaluation before clinical deployment.
T Cell Immunosenescence in Inflammatory Skin Diseases: Pathogenesis and Therapeutic Targets
Aging T cells develop senescence characteristics that drive chronic inflammatory skin diseases through dysregulated signaling pathways and secretion of pro-inflammatory factors. Targeting senescent T cells or their signaling cascades offers a mechanism-based approach to achieving sustained remission in conditions like psoriasis and atopic dermatitis.
Rubedo: the senolytic alchemist of aging biology
Rubedo Life Sciences has advanced RLS-1496, a first-in-class GPX4 modulator senolytic, through Phase 1 human trials based on the company's ALEMBIC AI platform for identifying senescent cell vulnerabilities. This represents a shift from repurposed compounds toward precision-targeted senolytics designed to eliminate dysfunctional cells while sparing healthy tissue.
Two Polyunsaturated Lipids Demonstrate Senolytic Activity
Two conjugated polyunsaturated fatty acids, α-eleostearic acid and its methyl ester, demonstrated senolytic activity in cell cultures and mouse models across multiple tissues without systemic toxicity. The structural features of these compounds—particularly conjugation patterns and double-bond configuration—correlate with their ability to eliminate senescent cells, which accumulate with age and drive inflammatory cascades linked to chronic disease.
Epigenetic reprogramming reverses aging at cellular level
Epigenetic reprogramming represents a shift from static aging theories to a dynamic model where gene expression patterns—not DNA sequence itself—drive aging processes and can be therapeutically reversed. This reframes longevity interventions from inevitable decline management to targeted restoration of youthful cellular states.
Plasma Proteomic Profiling of Young and Older Adults Identifies Candidate Biomarkers of Biological Aging at the Intersection of Age and Disease
Proteomic analysis identified 311 plasma proteins whose expression patterns correlate with both chronological age and disease burden in older adults, representing candidate biomarkers of biological aging. These proteins suggest shared regulatory pathways between aging and chronic disease progression and may enable risk stratification and intervention monitoring.
New COSRX peptide serum taps growing skin longevity market
COSRX's Blue Peptide Bakuchiol serum addresses emerging consumer demand for skin resilience and long-term health rather than antiaging reversal, specifically acknowledging how body composition changes—including from GLP-1 medications—affect facial firmness and elasticity. The product democratizes peptide-based skincare by making copper tripeptide-1 accessible at mid-market price points rather than luxury positioning.
Telomere Restoration in Blood Cells Without Adverse Effects
Elixirgen is advancing two distinct therapeutic approaches for rare diseases: EXG-7001, a locally administered dystrophin mRNA for Duchenne muscular dystrophy, and EXG-34217, which uses engineered stem cells to achieve sustained telomere elongation in patients with telomere biology disorders. Early Phase 1/2 data demonstrates telomere lengthening without adverse events over 24 months, establishing proof of concept for a mutation-independent intervention in a class of diseases where cellular aging accelerates prematurely.
The ‘rising tide’ of mitochondrial therapies in longevity
Mitochondrial dysfunction is increasingly recognized as a central mechanism underlying age-related disease, not merely a feature of rare genetic conditions. The FDA approval of elamipretide (Forzinity) for Barth syndrome represents the first regulatory validation of mitochondria-targeted therapeutics, positioning this class of drugs as potential interventions for common age-related conditions including neurodegeneration and cardiac disease.
Senotype classification reframes cellular aging as adaptive or pathological
Senescent cells—those that have stopped dividing—exhibit distinct molecular profiles and functional outcomes depending on their origin and microenvironment. This classification framework clarifies why some senescent states support tissue repair while others drive chronic inflammation and age-related disease, fundamentally shifting how we interpret cellular aging.
Plasma Proteome Profiling of Centenarian Across Switzerland Reveals Key Youth‐Associated Proteins
Plasma proteomics of Swiss centenarians identified 37 proteins maintaining a younger profile despite advanced age, with pathways implicating immune regulation, metabolic enzyme function, and extracellular matrix stability. These findings establish reproducible molecular signatures of healthy longevity across independent cohorts and suggest specific protein targets for aging intervention.
Senescent Cell Distribution Across Tissues Enables Targeted Aging Intervention
Senescent cells accumulate across tissues with age and vary significantly by organ type and species, revealing tissue-specific patterns of cellular aging. This spatiotemporal map establishes a foundation for understanding which senescent populations drive age-related decline and represent therapeutic targets for longevity interventions.
‘Age reversal is the only viable path for effective therapy’
Telocyte's founder argues that effective longevity intervention requires reversing aging at the cellular level rather than managing age-related diseases incrementally. The company is preparing a telomerase gene therapy trial in dogs, with the thesis that aging results from failed maintenance systems that can be reset rather than from inevitable biological decline.
Targeting Hyperoxia‐Induced Cellular Senescence in Developing Human Airway Cells: Senomorphics Versus Senolytics Versus Antioxidants
Moderate hyperoxia induces cellular senescence in developing airway tissue, with lasting consequences for lung function. Three mechanistically distinct interventions—Fucoidan, Dasatinib plus Quercetin, and MitoQ—each mitigate senescence through different pathways, offering potential strategies to prevent hyperoxia-related lung disease in premature infants.
Biotechs race to turn aging science into cell-based therapies
Multiple biotech companies are developing cell-based therapies targeting aging as an underlying condition rather than treating age-related diseases individually. The longevity biotech market is projected to grow from $9.86 billion in 2025 to $29.7 billion by 2034, driven by approaches using encapsulated cells, gene therapy, and stem cell platforms.
A Robust Senescence Response Helps Wounds Heal
Younger mice demonstrate faster wound healing due to a more robust senescent cell response, while the accumulation of senescent cells with age paradoxically impairs regeneration. This reveals a temporal window in which senescent cell activation supports tissue repair before becoming detrimental.
IgG Glycan Age Predicts Mortality; Plasma Exchange Reverses It
IgG N-glycome patterns independently predict all-cause mortality across 20,405 individuals and respond to intervention, meeting established criteria for a valid aging biomarker. Therapeutic plasma exchange produced the largest reduction in glycan age at 0.4 years per month, positioning glycan structure as both a mechanistic link to chronic inflammation and a measurable target for lifespan extension.
IgG Glycans Reverse Aging Markers via Plasma Exchange
IgG glycan patterns—sugar structures attached to immune antibodies—function as modifiable biological aging markers that predict mortality risk and respond to interventions like therapeutic plasma exchange. Analysis of over 20,000 individuals across 42 studies establishes glycans as measurable indicators of immune aging that shift toward healthier profiles with targeted interventions.
NADMED backs Cleveland Clinic transplant study
Cleveland Clinic's awarded research uses redox biology—specifically NAD and NADH measurement—to assess metabolic viability of donor organs during the ischemic period before transplantation. This work translates longevity science concepts into actionable clinical tools for organ quality assessment and transplant outcomes.
Correction to “Spatial Reorganization of Chromatin Architecture Shapes the Expression Phenotype of Therapy‐Induced Senescent Cells”
This correction addresses a published study on how senescent cells reorganize their chromatin architecture in response to therapeutic stress. Understanding the structural changes in non-dividing cells has direct implications for improving cellular resilience and longevity through better therapeutic design.
Senescent Cell Pathways: Primary vs Secondary Origins
Research distinguishes primary senescent cells (induced by direct damage like radiation) from secondary senescent cells (induced by signals from neighboring senescent cells). This heterogeneity in senescent cell populations has direct implications for understanding aging progression and designing interventions targeting cellular senescence.
Mitochondrial therapy restores metabolic function without appetite
MitoRx's MTRX31 targets mitochondrial dysfunction rather than appetite suppression, achieving significant fat loss while preserving muscle and metabolic function in preclinical models. This metabolic-first approach addresses a fundamental limitation of current obesity drugs: weight loss achieved through caloric restriction often comes with muscle loss and metabolic compromise.
In Vivo Macrophage Reprogramming Expands Regenerative Therapy Access
Resolution Therapeutics is developing an in vivo regenerative macrophage therapy that reprograms immune cells directly within the body using mRNA-carrying lipid nanoparticles, rather than extracting and modifying cells ex vivo. This approach could extend regenerative medicine access to patients with advanced liver disease and chronic inflammatory conditions by eliminating manufacturing complexity.
Senescent Factors Suppress Innate Antiviral Immunity in Aged Mice via Two Distinct Mechanisms
Senescent cells accumulate with age and suppress antiviral immunity through four secreted factors—GDF15, IGF1, IL1α, and IL6—via two distinct signaling pathways. Blocking these factors restores innate antiviral defense in aged mice, offering a mechanistic target to improve immune resilience against infection in older adults.